a public good project by the
Synthesis
Company
of California

© 2026

Eric D. Moher | doi.page

0 works0 citations0 h-index

Eric D. Moher

Eli Lilly (United States)(US)Indianapolis Zoo(US)

Publications by Year

Research Areas

Synthetic Organic Chemistry Methods, Microbial Natural Products and Biosynthesis, Asymmetric Synthesis and Catalysis, Phytochemical compounds biological activities, Cyclopropane Reaction Mechanisms

Most-Cited Works

→ Dibutyltin Oxide Catalyzed Selective Sulfonylation of α-Chelatable Primary Alcohols(1999)189 cited
→ Catalytic Regioselective Sulfonylation of α-Chelatable Alcohols: Scope and Mechanistic Insight(2002)155 cited
→ Synthetic studies on quassinoids: total synthesis of (-)-chaparrinone, (-)-glaucarubolone, and (+)-glaucarubinone(1993)97 cited
→ Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials(2008)78 cited
→ Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors(2005)74 cited
→ Development and Manufacturing GMP Scale-Up of a Continuous Ir-Catalyzed Homogeneous Reductive Amination Reaction(2016)59 cited

→ Synthesis of Cryptophycin 52 Using the Sharpless Asymmetric Dihydroxylation: Diol to Epoxide Transformation Optimized for a Base-Sensitive Substrate(2000)

51 cited

→ Lithium catalyzed hetero Diels-Alder reactions cyclocondensation of N-protected α-amino aldehydes with 1-methoxy-3-tert-butyldimethylsilyloxybutadiene in the presence of lithium perchlorate(1993)40 cited

→ Synthetic studies on quassinoids: total synthesis of simalikalactone D and assignment of the absolute configuration of the .alpha.-methylbutyrate ester side chain.(1992)39 cited

→ Process Development for a Key Synthetic Intermediate of LY2140023, a Clinical Candidate for the Treatment of Schizophrenia(2011)39 cited